Glycopyrrolate Injection
Product Images NDC 68083-376

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 68083-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate-spl-1ml-carton-label (Glycopyrrolate Spl 1ml Carton Label)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL, supplied as 25 single-dose 1 mL vials. The label indicates this is for intramuscular or intravenous administration and contains benzyl alcohol. It includes warnings such as 'Not for use in newborns' and storage instructions. The labeler is Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Glycopyrrolate-spl-1ml-container-label (Glycopyrrolate Spl 1ml Container Label)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL in a 1 mL single dose vial. The label states it contains benzyl alcohol and is for intramuscular or intravenous use. It includes storage instructions and is manufactured by Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Glycopyrrolate-spl-20ml-carton-label (Glycopyrrolate Spl 20ml Carton Label)

Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) label for injection by Gland Pharma Limited. The carton indicates multiple dose vials (10 x 20 mL) for intramuscular or intravenous administration, contains benzyl alcohol preservative, and states it is not for use in newborns. Storage instructions and regulatory notices are also visible.*

FDA Label Image

Glycopyrrolate-spl-20ml-container-label (Glycopyrrolate Spl 20ml Container Label)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) for intramuscular or intravenous use, multiple dose vial. Manufactured by Gland Pharma Limited, Hyderabad, India. Label includes storage instructions and mentions benzyl alcohol preservative, with a note not for use in newborns.*

FDA Label Image

Glycopyrrolate-spl-2ml-carton-label (Glycopyrrolate Spl 2ml Carton Label)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single-dose vials. The label shows 25 vials of 2 mL each. It includes warnings such as "Not for use in newborns" and "Contains benzyl alcohol." The injection is for intramuscular or intravenous administration, manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions specify 206C to 256C (686F to 776F).*

FDA Label Image

Glycopyrrolate-spl-2ml-container-label (Glycopyrrolate Spl 2ml Container Label)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single dose vial. Contains benzyl alcohol for intramuscular or intravenous use. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions specify 20°C to 25°C (68°F to 77°F) in a controlled room temperature environment. Includes barcode, lot, and expiration date fields.*

FDA Label Image

Glycopyrrolate-spl-5ml-carton-label (Glycopyrrolate Spl 5ml Carton Label)

Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) in multiple 5 mL vials. Label indicates use for intramuscular or intravenous administration, containing benzyl alcohol as preservative. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions and dosage references are noted, with warnings against use in newborns.*

FDA Label Image

Glycopyrrolate-spl-5ml-container-label (Glycopyrrolate Spl 5ml Container Label)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) multiple-dose vial, intended for intramuscular or intravenous administration. The label notes that it contains benzyl alcohol preservative and is not for use in newborns. Manufactured by Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

Chemical structure diagram of Glycopyrrolate showing its molecular formula (C19H28BrNO3) and molecular weight (398.33). The structure includes a bromide ion and highlights key functional groups consistent with the Glycopyrrolate molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.